Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of nOPV2 with and without bOPV in infants
NCT04579510Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nOPV2 in poliomyelitis, sponsored by Centers for Disease Control and Prevention. Started Feb 2021; status: completed.
02
Drugs
nOPV2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04579510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04579510.